These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26497450)

  • 21. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC; Sancak B; Gür D
    Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Miller CE; Batra R; Cooper BS; Patel AK; Klein J; Otter JA; Kypraios T; French GL; Tosas O; Edgeworth JD
    Clin Infect Dis; 2012 Mar; 54(5):591-600. PubMed ID: 22186774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?
    Yamaki J; Lee M; Shriner KA; Wong-Beringer A
    Diagn Microbiol Infect Dis; 2011 May; 70(1):124-30. PubMed ID: 21392923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of vancomycin MIC creep in Staphylococcus aureus.
    Diaz R; Ramalheira E; Afreixo V; Gago B
    J Glob Antimicrob Resist; 2017 Sep; 10():281-284. PubMed ID: 28751240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population structure and characterisation of Staphylococcus aureus from bacteraemia at multiple hospitals in China: association between antimicrobial resistance, toxin genes and genotypes.
    He W; Chen H; Zhao C; Zhang F; Li H; Wang Q; Wang X; Wang H
    Int J Antimicrob Agents; 2013 Sep; 42(3):211-9. PubMed ID: 23871455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong.
    Ho PL; Lo PY; Chow KH; Lau EH; Lai EL; Cheng VC; Kao RY
    J Infect; 2010 Feb; 60(2):140-5. PubMed ID: 19961873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The change and significance of vancomycin minimal inhibitory concentration against methicillin-resistant Staphylococcus aureus isolates from inpatients with lower respiratory tract infection].
    Yang W; He B; Ning YZ; Li Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):288-92. PubMed ID: 23945344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype diversity of methicillin-resistant Staphylococcus aureus in Shenyang, China.
    Tian SF; Chu YZ; Nian H; Li FS; Sun JM; Wang YL; Liu LW; Shang H
    Scand J Infect Dis; 2013 Dec; 45(12):915-21. PubMed ID: 24032434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.
    Musta AC; Riederer K; Shemes S; Chase P; Jose J; Johnson LB; Khatib R
    J Clin Microbiol; 2009 Jun; 47(6):1640-4. PubMed ID: 19369444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
    Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
    J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
    Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
    Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.
    Rojas L; Bunsow E; Muñoz P; Cercenado E; Rodríguez-Créixems M; Bouza E
    J Antimicrob Chemother; 2012 Jul; 67(7):1760-8. PubMed ID: 22556382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Martín-Gandul C; López-Medrano F; de Gopegui ER; Ramón Blanco J; García-Pardo G; Calbo E; Horcajada JP; Granados A; Jover-Sáenz A; Dueñas C; Pujol M;
    Clin Microbiol Infect; 2014 Apr; 20(4):361-7. PubMed ID: 23991832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR
    J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].
    Kırca Yılmaz S; Acuner IC; Strommenger B; Bek Y; Witte W
    Mikrobiyol Bul; 2014 Jan; 48(1):14-27. PubMed ID: 24506712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
    Pitz AM; Yu F; Hermsen ED; Rupp ME; Fey PD; Olsen KM
    J Clin Microbiol; 2011 Jan; 49(1):269-74. PubMed ID: 20962147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.
    Hsieh YC; Lin YC; Huang YC
    Medicine (Baltimore); 2016 Oct; 95(41):e5060. PubMed ID: 27741120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.